A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)

NCT03347123 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped A business decision made by Incyte after analysis of data from a sister study.

Conditions

Interventions

Sponsor

Incyte Corporation